My bookmarksSign up free
Source

Commission Implementing Regulation (EU) 2019/150 of 30 January 2019 amending Implementing Regulation (EU) No 686/2012 as regards the rapporteur Member State for the evaluation of the following active substances contained in plant protection products: deltamethrin, diflufenican, epoxiconazole, fluoxastrobin, prothioconazole and tebuconazole (Text with EEA relevance.)

Commission Implementing Regulation (EU) 2019/150 of 30 January 2019 amending Implementing Regulation (EU) No 686/2012 as regards the rapporteur Member State for the evaluation of the following active substances contained in plant protection products: deltamethrin, diflufenican, epoxiconazole, fluoxastrobin, prothioconazole and tebuconazole (Text with EEA relevance.)

Implementing Regulation (EU) 2019/150 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

Implementing Regulation (EU) No 686/2012 is amended in accordance with the Annex to this Regulation.

Article 2

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union . It shall apply from 30 March 2019.

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX The Annex to Implementing Regulation (EU) No 686/2012 is amended as follows: (1) Part A is amended as follows: (a) the entry for Deltamethrin is replaced by the following: Active substance Rapporteur Member State Co-rapporteur Member State ‘Deltamethrin AT’   (b) the entry for Diflufenican is replaced by the following: Active substance Rapporteur Member State Co-rapporteur Member State ‘Diflufenican CZ’   (c) the entry for Fluoxastrobin is replaced by the following: Active substance Rapporteur Member State Co-rapporteur Member State ‘Fluoxastrobin DE’   (d) the entry for Prothioconazole is replaced by the following: Active substance Rapporteur Member State Co-rapporteur Member State ‘Prothioconazole PL’   (2) Part B is amended as follows: (a) the entry for Epoxiconazole is replaced by the following: Active substance Rapporteur Member State Co-rapporteur Member State ‘Epoxiconazole PL’   (b) the entry for Tebuconazole is replaced by the following: Active substance Rapporteur Member State Co-rapporteur Member State ‘Tebuconazole DK’

Other acts of the same type
Commission Implementing Regulation (EU) 2025/2145 of 21 October 2025 amending Implementing Regulation (EU) 2024/2746 laying down rules for the application of Council Regulation (EC) No 1217/2009 setting up the Farm Sustainability Data Network and repealing Commission Implementing Regulation (EU) 2015/220Commission Implementing Regulation (EU) 2025/2200 of 21 October 2025 amending Implementing Regulation (EU) 2022/1186 as regards administrative changes to the Union authorisation of the biocidal product family L+R Propanol PT1 FamilyCommission Implementing Regulation (EU) 2025/2081 of 17 October 2025 imposing a definitive anti-dumping duty and definitively collecting the provisional duty imposed on imports of steel track shoes originating in the People’s Republic of ChinaCommission Regulation (EU) 2025/2084 of 17 October 2025 amending Regulation (EC) No 1333/2008 of the European Parliament and of the Council as regards the use of quillaia extract (E 999) and Commission Regulation (EU) No 231/2012 as regards the specifications for quillaia extract (E 999)Commission Implementing Regulation (EU) 2025/2086 of 17 October 2025 laying down, pursuant to Regulation (EU) 2021/2282 on health technology assessment, procedural rules for the interaction during, exchange of information on, and participation in, the preparation and update of joint clinical assessments of medical devices and in vitro diagnostic medical devices at Union level, as well as templates for those joint clinical assessmentsCommission Implementing Regulation (EU) 2025/2091 of 17 October 2025 laying down good manufacturing practice for veterinary medicinal products in accordance with Regulation (EU) 2019/6 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/2154 of 17 October 2025 laying down good manufacturing practice for active substances used as starting materials in veterinary medicinal products in accordance with Regulation (EU) 2019/6 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/2196 of 17 October 2025 laying down detailed rules for the implementation of Council Regulation (EC) No 1224/2009 as regards access to waters and resources, control of fisheries, surveillance, inspection and enforcement, deduction of quotas and fishing efforts, data and information, and repealing Commission Implementing Regulation (EU) No 404/2011Commission Implementing Regulation (EU) 2025/2074 of 16 October 2025 granting a Union authorisation for the biocidal product family B. Braun Medical Propanol Family in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Delegated Regulation (EU) 2025/2651 of 16 October 2025 amending Delegated Regulation (EU) 2021/1698 as regards certain criteria for the establishment of the list of high-risk third countries and high-risk productsCommission Delegated Regulation (EU) 2025/2652 of 16 October 2025 amending Delegated Regulation (EU) 2023/2429 as regards origin labelling for fruit and vegetables originating in the non-self-governing territory of Western SaharaCommission Implementing Regulation (EU) 2025/2067 of 15 October 2025 amending Regulation (EC) No 340/2008 on the fees and charges payable to the European Chemicals Agency pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next